Acrodermatitis chronica atrophicans epidemiology and demographics: Difference between revisions
No edit summary |
|||
| Line 7: | Line 7: | ||
{{CMG}}; {{AE}} {{Anahita}} | {{CMG}}; {{AE}} {{Anahita}} | ||
==Overview== | ==Overview== | ||
[[Acrodermatitis chronica atrophicans]] is a rare [[disease]]. The [[prevalence]] of [[acrodermatitis chronica atrophicans]] is estimated to include 10% of cases with [[lyme disease]] in Europe. The [[incidence]] of [[acrodermatitis chronica atrophicans]] increases with [[aging|age]] and commonly affects individuals in range of 40 to 70 years old with a [[median]] of 64 years old. However there are few [[case report|case reports]] on [[child|children]] who are [[diagnosis|diagnosed]] with [[acrodermatitis chronica atrophicans]]. [[Acrodermatitis chronica atrophicans]] affects [[female|women]] more than [[male|men]]. The majority of [[acrodermatitis chronica atrophicans]] cases are reported in northern, central and eastern Europe (most commonly in countries bordering the Baltic Sea). Lately few cases of [[acrodermatitis chronica atrophicans]] have been reported in the United States and Canada. | |||
==Epidemiology and Demographics== | ==Epidemiology and Demographics== | ||
Latest revision as of 11:06, 16 June 2021
|
Acrodermatitis chronica atrophicans Microchapters |
|
Differentiating Acrodermatitis chronica atrophicans from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Acrodermatitis chronica atrophicans epidemiology and demographics On the Web |
|
American Roentgen Ray Society Images of Acrodermatitis chronica atrophicans epidemiology and demographics |
|
FDA on Acrodermatitis chronica atrophicans epidemiology and demographics |
|
CDC on Acrodermatitis chronica atrophicans epidemiology and demographics |
|
Acrodermatitis chronica atrophicans epidemiology and demographics in the news |
|
Blogs on Acrodermatitis chronica atrophicans epidemiology and demographics |
|
Xyz Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Acrodermatitis chronica atrophicans epidemiology and demographics On the Web |
|
American Roentgen Ray Society Images of Acrodermatitis chronica atrophicans epidemiology and demographics |
|
FDA on Acrodermatitis chronica atrophicans epidemiology and demographics |
|
CDC on Acrodermatitis chronica atrophicans epidemiology and demographics |
|
Acrodermatitis chronica atrophicans epidemiology and demographics in the news |
|
Blogs on Acrodermatitis chronica atrophicans epidemiology and demographics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Anahita Deylamsalehi, M.D.[2]
Overview
Acrodermatitis chronica atrophicans is a rare disease. The prevalence of acrodermatitis chronica atrophicans is estimated to include 10% of cases with lyme disease in Europe. The incidence of acrodermatitis chronica atrophicans increases with age and commonly affects individuals in range of 40 to 70 years old with a median of 64 years old. However there are few case reports on children who are diagnosed with acrodermatitis chronica atrophicans. Acrodermatitis chronica atrophicans affects women more than men. The majority of acrodermatitis chronica atrophicans cases are reported in northern, central and eastern Europe (most commonly in countries bordering the Baltic Sea). Lately few cases of acrodermatitis chronica atrophicans have been reported in the United States and Canada.
Epidemiology and Demographics
Incidence
- Only 10% of lyme disease cases in European population have been presented with arodermatitis chronica atrophicans. [1]
Prevalence
- The prevalence of acrodermatitis chronica atrophicans is estimated to include 10% of cases with lyme disease in Europe.[2]
Age
- The incidence of acrodermatitis chronica atrophicans increases with age. [3]
- Acrodermatitis chronica atrophicans commonly affects individuals in range of 40 to 70 years old.[3]
- There are few case reports on children who are diagnosed with acrodermatitis chronica atrophicans.[4]
- In a study done on 693 patients with acrodermatitis chronica atrophicans median age of disease has been estimated 64 years old. [5]
Gender
- Acrodermatitis chronica atrophicans affects women more than men.[3][2]
- Based on several studies female predominance has been reported approximately 65-80 % in acrodermatitis chronica atrophicans patient.[6][7][8]
Region
- The majority of acrodermatitis chronica atrophicans cases are reported in northern, central and eastern Europe (most commonly in countries bordering the Baltic Sea).[3][9][10]
- Lately few cases of acrodermatitis chronica atrophicans have been reported in the United States which were associated to Lyme disease (besides European immigrants). [3][5]
- Few cases have been observed in Canada recently.[10]
References
- ↑ Smetanick MT, Zellis SL, Ermolovich T (2010). "Acrodermatitis chronica atrophicans: a case report and review of the literature". Cutis. 85 (5): 247–52. PMID 20540415.
- ↑ 2.0 2.1 "StatPearls". 2021. PMID 33085436 Check
|pmid=value (help). - ↑ 3.0 3.1 3.2 3.3 3.4 Khalili M, Wong RJ (2018). "Underserved Does Not Mean Undeserved: Unfurling the HCV Care in the Safety Net". Dig Dis Sci. 63 (12): 3250–3252. doi:10.1007/s10620-018-5316-9. PMC 6436636. PMID 30311153.
- ↑ Nadal, D; Gundelfinger, R; Flueler, U; Boltshauser, E (1988). "Acrodermatitis chronica atrophicans". Archives of Disease in Childhood. 63 (1): 72–74. doi:10.1136/adc.63.1.72. ISSN 0003-9888.
- ↑ 5.0 5.1 Ogrinc K, Maraspin V, Lusa L, Cerar Kišek T, Ružić-Sabljić E, Strle F (2021). "Acrodermatitis chronica atrophicans: clinical and microbiological characteristics of a cohort of 693 Slovenian patients". J Intern Med. doi:10.1111/joim.13266. PMID 33550695 Check
|pmid=value (help). - ↑ THYRESSON N (1949). "The penicillin treatment of acrodermatitis atrophicans chronica (Herxheimer)". Acta Derm Venereol. 29 (6): 572–621. PMID 18140373.
- ↑ Asbrink E, Hovmark A, Olsson I (1986). "Clinical manifestations of acrodermatitis chronica atrophicans in 50 Swedish patients". Zentralbl Bakteriol Mikrobiol Hyg A. 263 (1–2): 253–61. doi:10.1016/s0176-6724(86)80128-6. PMID 3577484.
- ↑ Weber K, Preac-Mursic V, Neubert U, Thurmayr R, Herzer P, Wilske B; et al. (1988). "Antibiotic therapy of early European Lyme borreliosis and acrodermatitis chronica atrophicans". Ann N Y Acad Sci. 539: 324–45. doi:10.1111/j.1749-6632.1988.tb31867.x. PMID 3056202.
- ↑ Asbrink E (1993). "Acrodermatitis chronica atrophicans". Clin Dermatol. 11 (3): 369–75. doi:10.1016/0738-081x(93)90092-q. PMID 8221518.
- ↑ 10.0 10.1 Scott JD (2020). "Presentation of Acrodermatitis Chronica Atrophicans Rashes on Lyme Disease Patients in Canada". Healthcare (Basel). 8 (2). doi:10.3390/healthcare8020157. PMC 7349802 Check
|pmc=value (help). PMID 32512846 Check|pmid=value (help).